Macromol

Macromol is a quarterly, fully open-access journal of macromolecular science published by MDPI in Basel since 2021, with a 2025 Journal Impact Factor of 7.2 and a rank of 9 among 96 journals in polymer science《大分子》是由（MDPI）自 2021 年起在巴塞尔出版的季刊，专注大分子科学并采用完全开放获取模式，2025 年影响因子为 7.2，在高分子科学领域 96 种期刊中位列第 9。

Scope

• The journal provides an advanced forum for theoretical and experimental research on macromolecules, publishing reviews, regular research papers, short communications and special issues该刊为大分子的理论与实验研究提供交流平台，发表综述、常规研究论文、短通讯与专刊。
• Coverage includes biomacromolecules such as carbohydrates, lipids, proteins, antibodies and nucleic acids覆盖范围包括碳水化合物、脂类、蛋白质、抗体与核酸等生物大分子。
• Coverage includes biopolymers of biological or renewable origin and biomimetic polymers, such as polysaccharides, glycosaminoglycans, cyclodextrins, biopolyesters, biopolyamides and biological polyacids覆盖范围包括生物来源或可再生来源的生物聚合物与仿生聚合物，如多糖、糖胺聚糖、环糊精、生物聚酯、生物聚酰胺与生物多元酸。
• Coverage includes chitosans and chitins, lignins and celluloses, tannins and polyaromatic polymers, and macrocycles, glycoproteins and proteoglycans覆盖范围包括壳聚糖与甲壳素、木质素与纤维素、单宁与多环芳烃聚合物，以及大环化合物、糖蛋白与蛋白聚糖。
• Coverage includes the synthesis of biomacromolecules and their chemical and biological modification and engineering覆盖范围包括生物大分子的合成及其化学与生物学改性和工程化。
• Coverage includes the physics, theory and modelling of biomacromolecules, including molecular simulation and conformational studies, and novel analytical and characterisation techniques覆盖范围包括生物大分子的物理、理论与建模，含分子模拟与构象研究，以及新的分析与表征技术。
• Coverage includes applications of biomacromolecules in medicine and nanomedicine, in pharmaceutics as active substances and excipients, and in food as bioactive ingredients and packaging覆盖范围包括生物大分子在医学与纳米医学中的应用、在制药中作为活性物质与辅料的应用，以及在食品中作为生物活性成分与包装材料的应用。

History

• Macromol was launched by MDPI with an opening editorial from its founding Editor-in-Chief and released its inaugural issue in 2021 as a quarterly journal《大分子》由（MDPI）创办，创刊主编撰写发刊词，2021 年推出创刊号，当时为季刊。^[1]
• Ana Maria Diez-Pascual served as the founding Editor-in-Chief from 2020 to 2025（Ana Maria Diez-Pascual）自 2020 年至 2025 年担任创刊主编。
• In 2025 Maria Cristina Bonferoni of the University of Pavia in Italy took over as Editor-in-Chief2025 年，意大利（University of Pavia）的（Maria Cristina Bonferoni）接任主编。
• The journal was indexed in Scopus from 2023 and in the Emerging Sources Citation Index from 2024, in both cases from volume 1 issue 1该刊自 2023 年被 Scopus 收录，自 2024 年被（Emerging Sources Citation Index）收录，两次收录均追溯至第 1 卷第 1 期。
• It received its first Journal Impact Factor of 4.4 for 2024 and rose to 7.2 for 2025, ranking 9 of 96 in polymer science该刊 2024 年首获影响因子 4.4，2025 年升至 7.2，在高分子科学领域位列 96 种期刊中的第 9 位。
• Articles are published under a CC BY licence with an article processing charge of 1200 Swiss francs, and the journal sets no limit on paper length provided full experimental details are given文章以（CC BY）许可发表，文章处理费为 1200 瑞士法郎，该刊对论文篇幅不设上限，但要求给出完整的实验细节。

Editors

• Maria Cristina Bonferoni of the Department of Drug Sciences at the University of Pavia in Italy is the Editor-in-Chief主编为意大利（University of Pavia）药物科学系的（Maria Cristina Bonferoni）。
• Her research interests include amphiphilic polymers, bioactive polysaccharides and RNA-based nanomedicines她的研究方向包括两亲性聚合物、生物活性多糖与基于 RNA 的纳米药物。
• The journal belongs to the Polymer and Macromolecular Science cluster of MDPI alongside Polymers, Gels, Polysaccharides and Membranes该刊与（Polymers）、（Gels）、（Polysaccharides）、（Membranes）同属（MDPI）的高分子与高分子科学期刊群。
• It publishes Special Issues and has run an annual PhD Thesis Award since 2022该刊出版专刊，并自 2022 年起每年评选博士学位论文奖。
• Manuscripts are submitted through the online system of MDPI and are peer reviewed, with the editorial office reporting 18 days from submission to first decision and 4 days from acceptance to publication稿件经（MDPI）在线系统投稿并接受同行评议，编辑部公布从投稿到首次决定为 18 天，从录用到出版为 4 天。
• The editorial office is based at MDPI in Basel, Switzerland编辑部设于瑞士巴塞尔的（MDPI）。